Nucleic acids, such as DNA and RNA, play a crucial role in gene therapies and vaccines, as they are responsible for storing and transmitting biological information. To facilitate their effectiveness, it is essential for these nucleic acids to enter cells with the aid of chemical carrier systems. Recent research from the Helmholtz-Zentrum Hereon proposes a novel strategy wherein these carriers are individually tailored to each specific nucleic acid rather than utilizing a single carrier for multiple nucleic acids. Such customization could significantly enhance the efficacy of vaccines, providing promising advancements in the field.

Challenges in Nucleic Acid Delivery

One of the primary challenges in administering nucleic acids in therapeutic interventions is their rapid degradation within the body. Moreover, these molecules have inherent difficulties in crossing cell membranes without help. Upon entry into the body, they are often met by the immune system, which may perceive them as foreign entities.

“Our body's protective mechanisms work against these biologically active substances that we want to deliver specifically to the cell.” – Dr. Hanieh Moradian, Helmholtz-Zentrum Hereon

Given these obstacles, an effective transport system is vital for protecting nucleic acids during transit and ensuring their entry into target cells without causing harm.

The Dominance of Lipid-Based Nanoparticles

Current clinical applications predominantly utilize lipid-based nanoparticles for nucleic acid delivery, which gained prominence through their successful application in COVID-19 vaccines. Although these lipid nanoparticles are efficient, they are not devoid of limitations, including:

  • Limited Stability: They may degrade before reaching their target.
  • Complex Manufacturing: Variations in production can affect consistency.

Polymers: A Promising Alternative

As a solution, researchers are turning toward polymer-based carrier systems. According to Dr. Moradian, the capacity to chemically modify polymers allows researchers to:

  • Adapt their structure for increased stability.
  • Enhance their longevity in the biological environment.
  • Develop controlled drug-release mechanisms suitable for long-term applications.

Traditionally, a single polymer carrier has been used for various nucleic acid types. However, the proposed approach emphasizes tailoring each carrier system to align with the specific properties of the nucleic acid payload. This method involves distinguishing factors such as:

  1. Chemical structure
  2. Size and mobility
  3. Interactions between the payload and carrier
  4. Embedding of carriers in larger structures

Artificial Intelligence: A Catalyst for Innovation

Artificial intelligence (AI) presents a transformative opportunity for accelerating the development of polymer-based carriers. Instead of the traditional labor-intensive material testing, researchers envision utilizing robotic systems to readily produce various polymer designs. The collected data regarding properties can be systematically analyzed to derive insights on:

  • How carrier characteristics influence payload delivery
  • Optimal carrier design predictions for specific nucleic acid types
“If we understand how certain properties of carriers and payload influence each other, we can feed this information into predictive models.” – Dr. Hanieh Moradian

Conclusion

As the quest for effective gene therapies continues, the exploration of polymer-based carriers combined with AI integration offers significant promise. By focusing on customized delivery systems, researchers aim to enhance the effectiveness of nucleic acid therapies, paving the way for more durable and efficient vaccines and treatments.

Publication Information

Authors Title Journal Year
Hanieh Moradian et al. Payload‐Driven Design of Polymeric Carriers for Nucleic Acid Delivery: Insights from Structure–Function Relationships Advanced Science 2025

References

[1] Moradian H., et al. (2025). _Advanced Science_. Payload‐Driven Design of Polymeric Carriers for Nucleic Acid Delivery.

[2] Science X. (2026). Retrieved March 26, 2026, from https://phys.org/news/2026-03-lipid-nanoparticles-custom-polymers-ai.html

Future Outlook

The development of personalized polymeric carriers, alongside advancements in AI, holds the potential to revolutionize gene therapy practices. By overcoming barriers associated with traditional delivery systems, these innovations may lead to more effective treatments, ultimately enhancing patient outcomes and therapeutic success.